Brussels, 15 March 2021 – In the current chaos of Covid vaccines in Europe – due to suspicions about the serum Astrazeneca, suspended in 11 countries and with a lot seized throughout Italy – quite positive news arrives from the study ofMom on the effect of messenger RNA-based vaccines (Moderna and Pfizer-Biontech) to stem the danger of variants of the Coronavirus.
Covid, the bulletin with the data on the infections of March 15
From the first studies done, he explains Marco Cavalry, responsible for the Ema vaccine strategy, the preparations of Moderna and Pfizer-Biontech they have a’excellent effectiveness against the new variants of Covid “. In the same way, also” the vaccine Johnson&Johnson, recently approved by the EMA “was found to be effective.
Vaccino Sputnik, Cavaleri (Ema): probable ok in May
But bad news for AstraZeneca: at the hearing of the Health Committee of the European Parliament, Cavaleri specified: “According to a small study on two thousand cases, the AstraZeneca it was found to be ineffective” against the South African variant. But it will be necessary to wait for “larger studies” to verify their real effectiveness.
© All rights reserved